Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples